Bidirectional Transfer of Raltegravir in an Ex Vivo Human Cotyledon Perfusion Model.

about

Bidirectional Transfer of Raltegravir in an Ex Vivo Human Cotyledon Perfusion Model.

Item

http://www.wikidata.org/entity/Q36887876

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Bidirectional Transfer of Raltegravir in an Ex Vivo Human Cotyledon Perfusion Model.

@en

type

Item

label

Bidirectional Transfer of Raltegravir in an Ex Vivo Human Cotyledon Perfusion Model.

@en

prefLabel

Bidirectional Transfer of Raltegravir in an Ex Vivo Human Cotyledon Perfusion Model.

@en

P1476

Bidirectional Transfer of Raltegravir in an Ex Vivo Human Cotyledon Perfusion Model.

@en

P2093

Carole Giraud

http://www.w3.org/2001/XMLSchema#string

Cécile Vinot

http://www.w3.org/2001/XMLSchema#string

Jean-Marc Tréluyer

http://www.w3.org/2001/XMLSchema#string

Laurent Gavard

http://www.w3.org/2001/XMLSchema#string

Laurent Mandelbrot

http://www.w3.org/2001/XMLSchema#string

P2860

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women

Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry.

Placental transfer of darunavir in an ex vivo human cotyledon perfusion model.

Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011.

Raltegravir pharmacokinetics during pregnancy.

Raltegravir is a substrate for SLC22A6: a putative mechanism for the interaction between raltegravir and tenofovir

Raltegravir concentrations in the genital tract of HIV-1-infected women treated with a raltegravir-containing regimen (DIVA 01 study)

Placental transfer of rilpivirine in an ex vivo human cotyledon perfusion model.

The ex vivo human placental transfer of the anti-HIV nucleoside inhibitor abacavir and the protease inhibitor amprenavir.

No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.

P304

3112-3114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00007-16

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Marc Tréluyer

Gilles Peytavin

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26833154

http://www.w3.org/2001/XMLSchema#string

P932

4862479

http://www.w3.org/2001/XMLSchema#string